Wild type AAV, recombinant AAV, and Adenovirus super infection impact on AAV vector mobilization
Abstract
Recombinant Adeno-associated viral vector (rAAV) mobilization is a largely theoretical process in which intact AAV vectors spread or "mobilize" from transduced cells and infect additional cells within, or external, of the initial host. This process can be replication independent (vector alone), or replication-dependent (de novo rAAV production facilitated by super-infection of both wild-type AAV (wtAAV) and Ad helper virus). Herein, rAAV production and mobilization with and without wtAAV were analyzed following plasmid transfection or viral transduction utilizing well established in vitro conditions and analytical measurements. During in vitro production, wtAAV produced the highest titer with rAAV-luc (4.1 Kb), rAAV-IDUA (3.7 Kb), and rAAV-NanoDysferlin (4.9 Kb) generating 2.5-, 5.9-, or 10.7-fold lower amounts, respectively. Surprisingly, cotransfection of a wtAAV and a rAAV plasmid resulted in a uniform decrease in production of wtAAV in all instances with a concomitant increase of rAAV such that wtAAV:rAAV titers were at a ratio of 1:1 for all constructs investigated. These results were shown to be independent of the rAAV transgenic sequence, size, transgene, or promoter choice and point to novel aspects of wtAAV complementation that enhance current vector production systems yet to be de fined. In a mobilization assay, a sizeable amount of rAAV recovered from infected 293 cell lysate remained intact and competent for a secondary round of infection (termed non-replicative mobilization). In rAAV infected cells co-infected with Ad5 and wtAAV, rAAV particle production was increased > 50-fold compared to non-replicative conditions. In addition, replicative dependent rAAV vectors mobilized and resulted in >1,000 -fold transduction upon a subsequent 2nd round infection, highlighting the reality of these theoretical safety concerns that can be manifested under various conditions. Overall, these studies document and signify the need for mobilization resistant vectors and the opportunity to derive better vector production systems.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Popularizing recombinant baculovirus-derived OneBac system for scaling-up production of all recombinant adeno-associated virus vector serotypes
- Adeno-associated virus (AAV2) can replicate its DNA by a rolling hairpin or rolling circle mechanism, depending on the helper virus.
Anouk Lkharrazi, Kurt Tobler, … Cornel Fraefel·bioRxiv·Nov 13, 2023
- Improved Genome Packaging Efficiency of AAV Vectors Using Rep Hybrids
Mario Mietzsch, Courtnee Eddington, … Mavis Agbandje‐McKenna·Journal of VirologyPeer-reviewed·Jul 21, 2021
- Transgene Expression in Cultured Cells Using Unpurified Recombinant Adeno-Associated Viral Vectors
Brian Benyamini, Meagan N. Esbin, … Anna C. Maurer·Journal of Visualized ExperimentsPeer-reviewed·Oct 20, 2023
- Methods Matter -- Standard Production Platforms For Recombinant AAV Produce Chemically And Functionally Distinct Vectors
Neil G. Rumachik, Stacy Alyse Malaker, … Nicole K. Paulk·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·May 21, 2020
- Temporal Insights into Molecular and Cellular Responses during rAAV Production in HEK293T Cells.
Alok Tanala Patra, Evan Tan, … Xuezhi Bi·Molecular Therapy — Methods & Clinical DevelopmentPeer-reviewed·Jun 8, 2024